Integrated Screening in Hit Identification
Despite the availability of modern screening technologies, identification and optimization of hits against poorly druggable targets remains a significant challenge for drug discovery teams. Generating hit matter and reference compounds with one screening technology and then screening with a second technology has the potential to be a powerful tool for researchers.
At this year’s Oxford Global Discovery Europe Conference, WuXi AppTec presented a poster highlighting a case study which employed a combination of different screening technologies, structural biology methods, and computational approaches to identify and advance hits with nanomolar potency against p38α.
Discovery Europe _Poster_Integrated Screening_final
Related Content
Molecular glues are molecules that can encourage two proteins to interact when they otherwise may not. As a consequence, they...
VIEW RESOURCETarget deconvolution, particularly when paired with proteomics techniques, plays a crucial role in drug discovery and target identification. By using...
VIEW RESOURCE